In a randomized, double-blind, placebo-controlled study of patients with well-controlled T2D, an NaPB add-on treatment of 4.8 g/m2/day over 2 weeks resulted in a 27% increase in peripheral insulin sensitivity, as well as decreases in plasma BCAA and glucose levels [111]. The gene discussed is INS; the disease is type 2 diabetes mellitus.